Author Correction: Covalent penicillin-protein conjugates elicit anti-drug antibodies that are clonally and functionally restricted

Affiliations

• ¹ Sir William Dunn School of Pathology, University of Oxford, Oxford, OX1 3RE, UK. Lachlan.Deimel@path.ox.ac.uk.
• ² Laboratory of Molecular Immunology, The Rockefeller University, New York, NY, 10065, USA. Lachlan.Deimel@path.ox.ac.uk.
• ³ Rosalind Franklin Institute, Harwell Science and Innovation Campus, Oxford, OX11 0FA, UK.
• ⁴ Department of Chemistry, University of Oxford, Oxford, OX1 3TA, UK.
• ⁵ Kavli Institute for Nanoscience Discovery, Dorothy Crowfoot Hodgkin Building, University of Oxford, Oxford, OX1 3QU, UK.
• ⁶ Department of Biochemistry, University of Oxford, Oxford, OX1 3QU, UK.
• ⁷ Sir William Dunn School of Pathology, University of Oxford, Oxford, OX1 3RE, UK.
• ⁸ Department of Pharmacology, University of Oxford, Oxford, OX1 3QT, UK.
• ⁹ Rosalind Franklin Institute, Harwell Science and Innovation Campus, Oxford, OX11 0FA, UK. Ben.Davis@chem.ox.ac.uk.
• ¹⁰ Department of Chemistry, University of Oxford, Oxford, OX1 3TA, UK. Ben.Davis@chem.ox.ac.uk.
• ¹¹ Department of Pharmacology, University of Oxford, Oxford, OX1 3QT, UK. Ben.Davis@chem.ox.ac.uk.
• ¹² Sir William Dunn School of Pathology, University of Oxford, Oxford, OX1 3RE, UK. Quentin.Sattentau@path.ox.ac.uk.
• ¹³ The Max Delbrück Centre for Molecular Medicine, Campus Berlin-Buch, 13125, Berlin, Germany. Quentin.Sattentau@path.ox.ac.uk.
• ¹⁴ Experimental and Clinical Research Center (ECRC), Charité Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine, Lindenberger Weg 80, 13125, Berlin, Germany. Quentin.Sattentau@path.ox.ac.uk.